Your Money with Michelle Martin
MONEY FM 89.3
Your Money With Michelle Martin (9am - 12pm) It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with “Influence” and hear from great authors in “Read”.
Episodes
Mentioned books
Apr 27, 2022 • 20min
Market View: Sembmarine & Keppel O&M merger, Yangzijiang's SGX spin-off, reactions from Alphabet's earnings
What is the new merger between Keppel Offshore & Marine and Sembcorp Marine going to look like? Why aren't Yangzijiang's leaders deterred from spinning off its investment arm despite the possibility of investors dropping the stock from their portfolios? Michelle Martin analyses it all with Ryan Huang.See omnystudio.com/listener for privacy information.
Apr 27, 2022 • 3min
Market View Minutes with Michelle Martin: Which bank stock is beating expectations?
HSBC and UBS, which one is beating expectations? Michelle Martin has it all.See omnystudio.com/listener for privacy information.
Apr 27, 2022 • 21min
Money and Me: Don't let high fees stand in your way of an MBA
Professor Ilian Mihov, Dean, INSEAD was once a student who caught sight of an advertisement for a scholarship for Bulgarian students to study in the US. He shares how he made it to a Princeton Phd on scholarship in this inspiring interview where he also shares his thoughts on who scholarships are for. Prof Mihov then slays a myth of how much an INSEAD education costs in this conversation with Michelle Martin.See omnystudio.com/listener for privacy information.
Apr 26, 2022 • 12min
Money and Me: Pullback for SNP possible given deteriorating backdrop for US stocks.
As investors prepare for major earnings reports this week Michelle Martin and Tony Sycamore, APAC Analyst, City Index discuss the odds of a market correction, reaction to the latest results of France's election and Musk takeover of Twitter. They also look at how Bitcoin is trading in a risk off environment.See omnystudio.com/listener for privacy information.
Apr 26, 2022 • 26min
Market View: Elon Musk seals US$44 billion Twitter deal, Coca-cola earnings beat Wall Street estimates, CSI 300 Index hits 2-year low
Elon Musk's done it, he will be buying Twitter for US$44 billion! So what does this mean for the company moving forward? Michelle Martin and Ryan Huang tell us all about it.See omnystudio.com/listener for privacy information.
Apr 26, 2022 • 3min
Market View Minutes with Michelle Martin: Which stocks stand to benefit from Twitter's privatization?
What could Twitter's privatization mean for other social media stocks? Michelle Martin finds out. See omnystudio.com/listener for privacy information.
Apr 25, 2022 • 20min
Market View: European markets react to Macron's victory, Earnings to watch, Elon Musk confronts Bill Gates
Michelle Martin and Ryan Huang explore the latest development following Macron's victory in his second presidential election, top corporate earnings to watch out for this week and Elon Musk's confronting Bill Gates about shorting Tesla. See omnystudio.com/listener for privacy information.
Apr 25, 2022 • 2min
Market View Minutes: It's official, call Jack Dorsey the 'Block Head'
Following in the footsteps of Musk, who crowned himself the Technoking of Tesla in 2021, Jack Dorsey's new title at Block is no longer CEO, but Block Head! Michelle Martin tells us more. See omnystudio.com/listener for privacy information.
Apr 25, 2022 • 10min
Money and Me: Cash upon hospitalisation - what are some considerations?
Just recently, HL Assurance announced the launch of Hospital Protect 360, a hospital income protection policy that is designed to bolster the unexpected financial expenses incurred in the event of unforeseen accidents or illnesses that is triggered even if you are hospitalized abroad for Covid. Michelle Martin learns more about it with Kelvin Lim, CEO, HL Assurance.See omnystudio.com/listener for privacy information.
Apr 25, 2022 • 17min
Influence: Renovatio Bioscience secures a new $20 million mega expansion deal with Woolworths!
Fast forward 8 months after its $10 million partnership with Woolworths, Renovatio Bioscience just revealed a new $20 million mega expansion deal with the supermarket giant to expand its range and introduce three new products. Dr Vincent Candrawinata, Founder, Renovatio Bioscience joins Michelle Martin to discuss more about Renovatio’s mega expansion deal with Woolworths and what his new products can offer to consumers. See omnystudio.com/listener for privacy information.
